0 CHECKOUT

Dabur India Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • ID: 2338549
  • June 2016
  • Region: India
  • 56 pages
  • MarketLine
1 of 3

Summary
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

This report includes Dabur India Limited's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Dabur India Limited. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Key Findings
Dabur India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), READ MORE >

Note: Product cover images may vary from those shown
2 of 3

COMPANY OVERVIEW AND KEY FACTS
Mergers and Acquisitions – Deal reports
PARTNERSHIP
Partnership – Overview
Partnership – Deal reports
DIVESTMENTS
Divestments – Overview
Divestments – Deal reports
PRIVATE EQUITY & OWNERSHIP
Private Equity and Ownership – Overview
Private Equity and Ownership – Deal reports

APPENDIX
About the Author Financial Deals Database
Deal Definition and Methodology
About the Author

List of Tables

Dabur India Limited activity by deal type – volume (2015-TTM2016)
Dabur India Limited activity by deal type – volume (2012 -YTD2016)
Dabur India Limited legal advisor ranking by value ($m)
Dabur India Limited targets and partners (2012 -YTD2016)
Dabur India Limited partnership volume and value trend (2012-YTD2016)
Dabur India Limited partnership trend by key deal type (2012-YTD2016)
Dabur India Limited divestments volume and value trend (2012-YTD2016)
Dabur India Limited divestments activity by geography (2012-YTD2016)
Dabur India Limited private equity and ownership volume and value trend (2012-YTD2016)
Dabur India Limited private equity and ownership activity by deal type (2012-YTD2016)

List of Figures

Dabur India Limited activity by deal type - volume (trailing twelve months (TTM))
Dabur India Limited activity by deal type - volume (2012-YTD2016)
Dabur India Limited partnership volume and value trend (2012-YTD2016)
Dabur India Limited partnership trend by key deal type (2012-YTD2016)
Dabur India Limited divestments volume and value trend (2012-YTD2016)
Dabur India Limited divestments by geography (2012-YTD2016)
Dabur India Limited private equity and ownership volume and value trend (2012-YTD2016)
Dabur India Limited private equity and ownership by deal type (2012-YTD2016)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.